Neutropenia due to infection (D70.3) is a clinical condition characterized by an absolute neutrophil count (ANC) significantly lower than the standard range (typically below 1,500 cells/µL), occurring as a direct consequence of an infectious process. This hematological abnormality can arise through several mechanisms: direct suppression of granulopoiesis in the bone marrow by viruses or intracellular bacteria, increased peripheral destruction or sequestration of neutrophils in the spleen or lungs, and accelerated consumption of the neutrophil pool during overwhelming sepsis. While many viral infections cause a mild and transient neutropenia, certain pathogens like HIV, Epstein-Barr virus (EBV), and Cytomegalovirus (CMV), as well as severe bacterial infections such as typhoid fever or septicemia, can lead to profound and clinically significant neutropenia that increases the risk of secondary opportunistic infections.
Explicitly link the neutropenia to the causative infection using definitive causal language.
Example: Patient with acute absolute neutrophil count of 450 per microliter, which is documented as neutropenia due to current severe influenza A infection. This linkage between D70.3 and J10.1 is critical for establishing medical necessity and higher severity of illness for risk adjustment.
Billing Focus: Documentation must specify the infectious agent to support the code selection of D70.3 over non-specific neutropenia codes.
Document the Absolute Neutrophil Count to substantiate the severity of the neutropenia.
Example: Clinical assessment confirms severe neutropenia with an ANC of 300 cells/uL directly resulting from systemic cytomegalovirus infection. The severe nature of the neutropenia (ANC below 500) justifies more intensive management and higher risk categorization.
Billing Focus: Numerical laboratory values provide objective evidence for the diagnosis code D70.3.
Specify the clinical manifestation of the neutropenia such as fever or mucosal ulcers.
Example: Patient presents with febrile neutropenia due to acute pyelonephritis. ANC is 600. The presence of fever increases the clinical complexity. Coding reflects D70.3 along with R50.81 for the febrile component.
Billing Focus: Reporting associated symptoms like fever (R50.81) alongside D70.3 provides a complete clinical picture for multi-layered billing.
Differentiate between acute and chronic infection-related neutropenia.
Example: Diagnosis is acute neutropenia due to acute Epstein-Barr virus infection. ANC is 750. This is a transient, acute state expected to resolve with the infection. This specificity prevents confusion with chronic congenital forms.
Billing Focus: Acute status supports the use of specific infectious diagnosis codes and prevents denials associated with chronic condition reporting.
Document the treatment plan, including prophylactic measures or growth factors used.
Example: Neutropenia due to Hepatitis C infection; ANC 800. Initiating prophylactic Levofloxacin and monitoring ANC bi-weekly. Treatment plan demonstrates the active management of the D70.3 diagnosis.
Billing Focus: Clear treatment plans support the medical necessity of the E/M level chosen.
Used for monitoring stable patients with mild neutropenia where diagnostic data review is straightforward.
Appropriate when managing neutropenia with active infection requiring prescription drug management and detailed data review.
Essential for establishing the diagnosis of D70.3 and monitoring recovery.
Performed when the cause of neutropenia is unclear or marrow suppression is suspected.
Used for the administration of G-CSF (e.g., Filgrastim) in severe cases.
The pharmaceutical agent used to treat severe neutropenia.
Used for the initial evaluation of a patient presenting with new-onset infection and low WBC counts.
Confirms the infectious etiology of neutropenia in mononucleosis cases.
Used to identify CMV-induced marrow suppression.
Used for complex patients with severe infection, multiple comorbidities, and life-threatening neutropenia.